Home
Home
About
Contact
Begin your search of the AGOSR Open Access Database
Search
Reset
All Fields
Contributors
DOI
OAI
Results: 1
View Article
A double blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive iron.
Amat Bah
,
Rita Wegmuller
,
Carla Cerami
,
Lindsay Kendall
,
Sant-Rayn Pasricha
,
Sophie E Moore
,
Andrew M Prentice
Sep 29, 2016
BACKGROUND: Until recently, WHO recommended daily iron supplementation for all pregnant women (60 mg/d iron combined with 400ug/d folic acid) where anaemia rates exceeded 40 %. Recent studies indicate that this may pose a risk...
anaemia
Hepcidin
Iron deficiency
Lower dose iron
Pregnancy
UNIMMAP
Adult
Anemia
Iron-Deficiency
Biomarkers
Dietary Supplements
Double-Blind Method
Female
Gambia
Hepcidins
Humans
Iron
Maternal Serum Screening Tests
Pregnancy
Pregnancy Complications
Randomized Controlled Trials as Topic
trace elements
Treatment Outcome
Young Adult
Published by: